Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 72

1.

Clinical implications of hypoxia biomarker expression in head and neck squamous cell carcinoma: a systematic review.

Swartz JE, Pothen AJ, Stegeman I, Willems SM, Grolman W.

Cancer Med. 2015 Apr 27. doi: 10.1002/cam4.460. [Epub ahead of print]

2.

A systematic review of pharmacological treatment options used to reduce ischemia reperfusion injury in rat liver transplantation.

Yamanaka K, Houben P, Bruns H, Schultze D, Hatano E, Schemmer P.

PLoS One. 2015 Apr 28;10(4):e0122214. doi: 10.1371/journal.pone.0122214. eCollection 2014.

3.

Rituximab for treating inhibitors in people with inherited severe hemophilia.

Liu Y, Zhang L, Santoro C, Song J, Rodriguez A, Wang L.

Cochrane Database Syst Rev. 2015 Apr 4;4:CD010810. doi: 10.1002/14651858.CD010810.pub2.

PMID:
25841099
4.

Violating the theory of single gene-single disorder: inhibitor development in hemophilia.

AlFadhli S, Nizam R.

Indian J Hematol Blood Transfus. 2015 Jun;31(2):162-8. doi: 10.1007/s12288-014-0473-2. Epub 2014 Nov 20. Review.

PMID:
25825553
5.

Research in haemophilia B--approaching the request for high evidence levels in a rare disease.

Berger K, Schopohl D, Hilger A, Behr Gross ME, Giangrande P, Peyvandi F, Seitz R, Schramm W.

Haemophilia. 2015 Jan;21(1):4-20. doi: 10.1111/hae.12603. Epub 2014 Dec 11.

PMID:
25495927
6.

A systematic review of prothrombin complex concentrate dosing strategies to reverse vitamin K antagonist therapy.

Khorsand N, Kooistra HA, van Hest RM, Veeger NJ, Meijer K.

Thromb Res. 2015 Jan;135(1):9-19. doi: 10.1016/j.thromres.2014.11.019. Epub 2014 Nov 22.

PMID:
25480313
7.

Gene therapy for haemophilia.

Sharma A, Easow Mathew M, Sriganesh V, Neely JA, Kalipatnapu S.

Cochrane Database Syst Rev. 2014 Nov 14;11:CD010822. doi: 10.1002/14651858.CD010822.pub2. Review.

PMID:
25394678
8.

Inhibitors in haemophilia: what have we learned from registries? A systematic review.

Osooli M, Berntorp E.

J Intern Med. 2015 Jan;277(1):1-15. doi: 10.1111/joim.12301. Epub 2014 Sep 18. Review.

PMID:
25169114
9.

Development of aptamer oligonucleotides as anticoagulants and antithrombotics for cardiovascular diseases: current status.

Li W, Wang K, Zhao M, Yang X, Chen M, Lan X.

Thromb Res. 2014 Oct;134(4):769-73. doi: 10.1016/j.thromres.2014.05.021. Epub 2014 May 22. Review.

PMID:
25113995
10.

Immunosuppressive agents in the treatment of inhibitors in congenital haemophilia A and B--a systematic literature review.

Laros-van Gorkom BA, Falaise C, Astermark J.

Eur J Haematol Suppl. 2014 Aug;76:26-38. doi: 10.1111/ejh.12372. Review.

PMID:
24957105
11.

Methods for individualising factor VIII dosing in prophylaxis.

Ar MC, Vaide I, Berntorp E, Björkman S.

Eur J Haematol Suppl. 2014 Aug;76:16-20. doi: 10.1111/ejh.12370. Review.

PMID:
24957103
12.

Outcome measures in haemophilia: a systematic review.

Boehlen F, Graf L, Berntorp E.

Eur J Haematol Suppl. 2014 Aug;76:2-15. doi: 10.1111/ejh.12369. Review.

PMID:
24957102
13.

The potential of hypoxia markers as target for breast molecular imaging--a systematic review and meta-analysis of human marker expression.

Adams A, van Brussel AS, Vermeulen JF, Mali WP, van der Wall E, van Diest PJ, Elias SG.

BMC Cancer. 2013 Nov 10;13:538. doi: 10.1186/1471-2407-13-538. Review.

14.

The expression of hypoxia-inducible factor-1α and its clinical significance in lung cancer: a systematic review and meta-analysis.

Ren W, Mi D, Yang K, Cao N, Tian J, Li Z, Ma B.

Swiss Med Wkly. 2013 Sep 6;143:w13855. doi: 10.4414/smw.2013.13855. Review.

15.

Applicability of the European Society of Cardiology guidelines on management of acute coronary syndromes to people with haemophilia - an assessment by the ADVANCE Working Group.

Staritz P, de Moerloose P, Schutgens R, Dolan G; ADVANCE Working Group.

Haemophilia. 2013 Nov;19(6):833-40. doi: 10.1111/hae.12189. Epub 2013 May 28.

PMID:
23710576
16.

The clinical use of prothrombin complex concentrate.

Ferreira J, DeLosSantos M.

J Emerg Med. 2013 Jun;44(6):1201-10. doi: 10.1016/j.jemermed.2012.12.022. Epub 2013 Apr 18. Review.

PMID:
23602147
17.

Issues in pediatric haemophilia care.

Giordano P, Franchini M, Lassandro G, Faienza MF, Valente R, Molinari AC.

Ital J Pediatr. 2013 Apr 20;39:24. doi: 10.1186/1824-7288-39-24. Review.

18.

Thrombotic complications in patients with PMM2-CDG.

Linssen M, Mohamed M, Wevers RA, Lefeber DJ, Morava E.

Mol Genet Metab. 2013 May;109(1):107-11. doi: 10.1016/j.ymgme.2013.02.006. Epub 2013 Feb 16.

PMID:
23499581
19.

An update of consensus guidelines for warfarin reversal.

Tran HA, Chunilal SD, Harper PL, Tran H, Wood EM, Gallus AS; Australasian Society of Thrombosis and Haemostasis (ASTH).

Med J Aust. 2013 Mar 4;198(4):198-9.

PMID:
23451962
20.

I smell a rat: a case report and literature review of paradoxical thrombosis and hemorrhage in a patient with brodifacoum toxicity.

Franco D, Everett G, Manoucheri M.

Blood Coagul Fibrinolysis. 2013 Mar;24(2):202-4. doi: 10.1097/MBC.0b013e328358e959.

PMID:
23358203
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk